In vitro and in vivo studies of ME1228, a new parenteral cephalosporin with potent activity against Pseudomonas aeruginosa.
AUTOR(ES)
Miyazaki, S
RESUMO
The therapeutic effect of ME1228, a new parenteral cephalosporin, was compared with that of broad-spectrum cephems in normal and neutropenic mice infected with various species of bacteria. The results showed that ME1228 was more active than were the other cephems against infections with various pathogens.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=284323Documentos Relacionados
- In vitro activity of ME1228, a new parenteral cephalosporin.
- In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa.
- In vitro activity of SCE-2787, a new cephalosporin with potent activity against Pseudomonas aeruginosa and members of the family Enterobacteriaceae.
- In vitro activity of FK037, a new parenteral cephalosporin, against anaerobic bacteria.
- Cefazaflur, a New Parenteral Cephalosporin: In Vitro Studies
